Peer Review reports
From: A clinical study of genetic testing to guide the dosing of warfarin after heart valve replacement
| Original Submission | ||
|---|---|---|
| 31 May 2021 | Submitted | Original manuscript |
| Resubmission - Version 2 | ||
| Submitted | Manuscript version 2 | |
| 7 Dec 2021 | Reviewed | Reviewer Report |
| 24 Dec 2021 | Reviewed | Reviewer Report |
| 21 Jan 2022 | Author responded | Author comments - Jingxing Li |
| Resubmission - Version 3 | ||
| 21 Jan 2022 | Submitted | Manuscript version 3 |
| 25 Feb 2022 | Author responded | Author comments - Jingxing Li |
| Resubmission - Version 4 | ||
| 25 Feb 2022 | Submitted | Manuscript version 4 |
| 10 Mar 2022 | Author responded | Author comments - Jingxing Li |
| Resubmission - Version 5 | ||
| 10 Mar 2022 | Submitted | Manuscript version 5 |
| 6 Apr 2022 | Reviewed | Reviewer Report |
| Resubmission - Version 6 | ||
| Submitted | Manuscript version 6 | |
| Publishing | ||
| 8 Apr 2022 | Editorially accepted | |
| 19 Apr 2022 | Article published | 10.1186/s12872-022-02620-x |
You can find further information about peer review here.